CIK 0001125345
- Non-accelerated filer
- Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-16 | Spitznagel Thomas Sr VP, BPD & Manufacturing | Exercise or conversion · Employee stock option (right to buy) | −5,000 | $7.51 | $38K | 37,147 |
| 2021-06-24 | Bonvini Ezio Sr VP, Research & CSO | Exercise or conversion | +21,855 | $16.00 | $350K | 104,329 |
| 2021-06-24 | Bonvini Ezio Sr VP, Research & CSO | Exercise or conversion | +4,221 | $20.53 | $87K | 108,550 |
| 2021-06-24 | Bonvini Ezio Sr VP, Research & CSO | Exercise or conversion · Employee stock option (right to buy) | −21,855 | $16.00 | $350K | 2,540 |
| 2021-06-24 | Bonvini Ezio Sr VP, Research & CSO | Exercise or conversion · Employee stock option (right to buy) | −4,221 | $20.53 | $87K | 63,279 |
| 2021-06-21 | BIOTECH TARGET N V 10% owner | Purchase | +75,000 | $21.74 | $1.6M | 6,275,564 |
| 2021-06-16 | BIOTECH TARGET N V 10% owner | Purchase | +100,000 | $21.04 | $2.1M | 6,200,564 |
| 2021-06-15 | BIOTECH TARGET N V 10% owner | Purchase | +75,000 | $20.53 | $1.5M | 6,100,564 |
| 2021-05-14 | Bonvini Ezio Sr VP, Research & CSO | Exercise or conversion | +5,000 | 84,890 | ||
| 2021-05-14 | Bonvini Ezio Sr VP, Research & CSO | Shares withheld for taxes | −2,416 | $29.49 | $71K | 82,474 |
| 2021-05-14 | Bonvini Ezio Sr VP, Research & CSO | Exercise or conversion · Restricted Stock Unit | −5,000 | 5,000 | ||
| 2021-05-13 | O'Brien Federica F. Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-05-13 | STUMP DAVID C Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-05-13 | SIEGEL JAY PHILIP Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-05-13 | Jackson Scott Thomas Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-05-13 | HURWITZ EDWARD Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-05-13 | Galbraith Kenneth Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-05-13 | Ferrante Karen Jean Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-05-13 | Costa Paulo F Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-04-15 | Spitznagel Thomas Sr VP, BPD & Manufacturing | Exercise or conversion | +5,000 | $7.51 | $38K | 5,000 |
Page 23 of 26 · 503 trades